Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Dose and treatment duration of bDMARD therapy
| bDMARD | Patients, n (%) | Weekly dose (mg) | Treatment duration (weeks) | ||
|---|---|---|---|---|---|
| Mean (SD) | Median (range) | Mean (SD) | Median (range) | ||
| Etanercept | 534 (66.6) | 38.2 (15.6) | 50 (2.1–100.0) | 25.5 (47.0) | 6.0 (0.1–350.0) |
| Tocilizumab | 136 (17.0) | 94.5 (21.9) | 100 (30.0–160.0) | 4.7 (7.5) | 1.0 (0.1–34.0) |
| Adalimumab | 60 (7.5) | 20.1 (6.4) | 20.0 (5.0–40.0) | 12.7 (19.4) | 4.0 (0.1–104.0) |
| Infliximab | 53 (6.6) | 33.1 (23.6) | 25.0 (3.8–100.0) | 34.5 (39.1) | 24.0 (0.1–186.0) |
